Biotech Stocks Healthcare Stocks Life Sciences

Healthcare Was the Worst ASX 200 Sector in FY26, But Here’s Why FY27 Will Be Better!

What was worst ASX 200 Sector in FY26? With a 36% decline, it was healthcare. Technology fell by a similar amount, but while you could argue you'd expect tech to…

ByNick Sundich

01

Jul 2026

Blue Chip Stocks Agriculture Stocks AI Stocks Airlines Bank Stocks Basic Materials Biotech Stocks Cannabis Stocks CleanTech Coal Stocks Cobalt Stocks Consumer Copper Stocks Cryptocurrencies Currency Currency Forecast Cybersecurity Stocks Defence Stocks Dividend Stocks Education Education Stocks Energy Stocks ETF EV Stocks Financials Gaming Stocks General Gold Stocks Graphite Stocks Green Investments Growth Stocks Healthcare Stocks Hydrogen Stocks Index Funds Industrials International Stocks IPOs Iron Ore Stocks Large Caps Life Sciences Lithium Stocks Market news Mid Cap Stocks Mining Stocks News Nickel Stocks Oil and Gas Stocks Palladium Stocks Penny Stocks Property Rare Earths Stocks Real Estate Renewable Energy Stocks Resources Retail Safe Stocks Semiconductor stocks Silver stocks Small Caps Stocks Solar Energy Stocks Space Stocks Steel Stocks Tax Strategy Tax Stretegy Tech Stocks Technology Telecommunications Stocks Travel Stocks Undervalued Stocks Uranium Stocks US stocks Vanadium Stocks

ASX Stocks to Buy in FY27: Here Are Our Top 10 To Watch!

Today is the first day of the new financial year, and we think plenty of investors are wondering which ASX Stocks to Buy in FY27. Stocks Down Under recaps 10…

ByNick Sundich

26

Jun 2026

Biotech Stocks Healthcare Stocks Life Sciences Tech Stocks Technology

Here Are 5 ASX Stocks Pro Medicus Could Buy Next And If They Even Make Sense

What ASX Stocks Pro Medicus Could Buy Next? Pro Medicus (ASX:PME) has never been a serial acquirer since it picked up Visage at a bargain price during the GFC. But…

ByNick Sundich

25

Jun 2026

AI Stocks Healthcare Stocks Tech Stocks

Pro Medicus (ASX:PME) writes a A$20m cheque into Echo IQ

Pro Medicus (ASX:PME) commits up to A$20m to Echo IQ via secured convertible notes and becomes US reseller of EchoSolv, signalling a platform shift.

ByCharlie Youlden

05

Jun 2026

Tech Stocks Technology

Just because the worst of the Saaspocolypse may be over, it doesn’t mean all ASX tech stocks will grow. Here are 4 to buy and 4 to avoid!

The Saaspocolypse that has endured throughout the first half of 2026 has been a reminder that even the strongest structural themes can suffer violent drawdowns. Software stocks entered the year…

ByNick Sundich

01

Jun 2026

Healthcare Stocks Large Caps Tech Stocks

Pro Medicus (ASX:PME): A 7-year A$16m deal with TidalHealth is the latest Visage adoption!

Pro Medicus (ASX:PME) has signed a 7-year, A$16m contract with TidalHealth covering the full Visage 7 stack plus cardiology, delivered in the cloud.

ByCharlie Youlden

19

May 2026

AI Stocks ETF Tech Stocks Technology

How To Get Around the CGT Changes on ETFs? Its Hard, But This Could Be The Best Idea

It has been nearly a week that we've had time to digest the CGT Changes on ETFs. Yes, you read correct: after months of thought that any CGT changes could…

ByNick Sundich

18

May 2026

Healthcare Stocks

Pro Medicus (ASX:PME) Wins A$90m Beth Israel Lahey Deal: Buy the Dip or Wait After 56% Crash?

Pro Medicus Wins A$90m Beth Israel Lahey Deal Pro Medicus (ASX:PME) has landed another major US contract, signing a seven-year, A$90m deal with Beth Israel Lahey Health, a Boston-based hospital…

ByUjjwal Maheshwari

15

Apr 2026

Healthcare Stocks

Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

Pro Medicus Secures A$80M Amid 60% Selloff Pro Medicus (ASX:PME) jumped 4.3% on Monday after securing a A$37 million contract renewal with Northwestern Medicine at higher per-exam fees than its…

ByUjjwal Maheshwari

09

Apr 2026

Healthcare Stocks

Pro Medicus (ASX:PME) Rallies on $23m Maryland Contract. Is This the Dip Investors Should Be Buying?

Pro Medicus jumps on new US contract Pro Medicus (ASX:PME) jumped more than 8% on Wednesday after sealing a five-year, A$23 million contract with the University of Maryland Medical System.…

ByUjjwal Maheshwari

Healthcare Was the Worst ASX 200 Sector in FY26, But Here’s Why FY27 Will Be Better!

ASX Stocks to Buy in FY27: Here Are Our Top 10 To Watch!

Here Are 5 ASX Stocks Pro Medicus Could Buy Next And If They Even Make Sense

Pro Medicus (ASX:PME) writes a A$20m cheque into Echo IQ

Just because the worst of the Saaspocolypse may be over, it doesn’t mean all ASX tech stocks will grow. Here are 4 to buy and 4 to avoid!

Pro Medicus (ASX:PME): A 7-year A$16m deal with TidalHealth is the latest Visage adoption!

How To Get Around the CGT Changes on ETFs? Its Hard, But This Could Be The Best Idea

Pro Medicus (ASX:PME) Wins A$90m Beth Israel Lahey Deal: Buy the Dip or Wait After 56% Crash?

Pro Medicus (ASX:PME) Banks A$80M in One Month: Is the 60% Selloff Finally a Buy?

Pro Medicus (ASX:PME) Rallies on $23m Maryland Contract. Is This the Dip Investors Should Be Buying?

Stocks in Spotlight

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Stocks in Spotlight

Add Your Heading Text Here